Evaluation of the Relationship Between Factor IX Inhibitor in Hemophilia B Patients and Different Types of Therapy in the North-eastern Part of Iran

Journal Title: Iranian Journal of Blood and Cancer - Year 2009, Vol 1, Issue 2

Abstract

Background: Hemophilia B is a bleeding disorder with a recessive X-linked inheritance pattern, in which the infected individuals have low levels of factor IX in their plasma. Affected individuals may have bleeding episodes after trauma or spontaneously considering the plasma level of factor IX. In order to prevent these episodes and to control bleeding, they should use coagulation factor concentrates that may be associated with the formation of inhibitors. Methods: This study was conducted in the northeast of Iran in 2006. Among 48 individuals who agreed to participate in our survey, 3 individuals (6.25%) had used FFP, 38 s (79.16%) factor IX concentrate and 7 (14.58 both FFP and factor IX concentrate in the 6 months prior to the study. Of them, three participants (6.3%) had factor IX inhibitor which was assayed using Bethesda method. Results: Three hemophilia B (6.3%) patients had factor IX inhibitor, but no correlation was found between the existence of the inhibitor and the type of coagulation therapy. Conclusion: Our findings did not show any correlation between factor IX inhibitor and type of coagulation therapy used in the 6 month period (p=0.65). None of the hemophiliacs had used coagulation factor as a prophylaxis regimen and most of them (83.33%) had injected coagulation factor on demand.

Authors and Affiliations

Hassan Mansouri Torghabeh, Aliakbar Pourfathollah, Mahmoud Mahmoudian Shoushtari

Keywords

Related Articles

Association of Acute Lymphoblastic Leukemia and MDR1 Gene Polymorphism in an Ethnic Iranian Population

Background: The frequency of the multi-drug resistance 1 (MDR1) gene C3435T polymorphism differs in various ethnical populations such as Asian, African, and Caucasians populations. A silent C3435T polymorphism in exon 26...

Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation

The Quality centers shall build up a quality system. This comprises all activi-ties in the blood center intended to ensure that all blood and all components have a quality corresponding to the intended use. Quality Assu...

A Retrospective Analysis of Neuroendocrine Tumors in West Azarbaijan Province, Iran

Neuroendocrine tumors are most often located in the intestine and lungs but they can arise from other areas of the body. Limited data is available on epidemiology and clinical patterns of neuroendocrine tumors in Iran. W...

Pediatric Meduloblastoma and the Prognostic Value of MIB-1 Proliferative Factor

Background: Medulloblastoma is the most common malignant brain tumor in children. The important factors in predicting survival are the extent of disease, proliferation index of the tumor cells, histopathologic class and...

Download PDF file
  • EP ID EP383633
  • DOI -
  • Views 87
  • Downloads 0

How To Cite

Hassan Mansouri Torghabeh, Aliakbar Pourfathollah, Mahmoud Mahmoudian Shoushtari (2009). Evaluation of the Relationship Between Factor IX Inhibitor in Hemophilia B Patients and Different Types of Therapy in the North-eastern Part of Iran. Iranian Journal of Blood and Cancer, 1(2), 83-86. https://europub.co.uk/articles/-A-383633